|

T-Cell therapy Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since May 2026

Pipeline

Phase 1: 2

Top Sponsors

  • H. Lee Moffitt Cancer Center and Research Institute1
  • David Avigan1

Indications

  • Cancer2
  • Acute Myeloid Leukemia, in Relapse1
  • Acute Myeloid Leukemia1
  • HER2-positive Breast Cancer1
  • Breast Cancer1

Tampa, Florida1 trial

Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer

Moffitt Cancer Center

Phase 1

Boston, Massachusetts1 trial

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Beth Israel Deaconess Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.